Alprostadil (Caverject/MUSE) Cost in Tennessee 2026

What Does Alprostadil Actually Cost in Tennessee Right Now?

Retail pharmacy pricing for brand-name Caverject and MUSE in Tennessee averages close to $600 per month in 2026, though exact figures shift by pharmacy and dose. Cash-pay patients at large Tennessee chains such as CVS or Walgreens generally see prices near this figure for a typical monthly supply of intracavernosal injections or urethral suppositories.

Alprostadil is a synthetic prostaglandin E1 that relaxes smooth muscle in the corpus cavernosum, increasing arterial blood flow to produce an erection [1]. The FDA approved the intracavernosal form (Caverject) in 1995 and the intraurethral suppository form (MUSE) in 1996 [2]. Both forms require a prescription in Tennessee, and neither is available over the counter.

The landmark Linet et al. trial published in the New England Journal of Medicine (N=683) demonstrated that intracavernosal alprostadil produced satisfactory erections in 94% of injections compared with 41% for placebo, establishing the clinical rationale for the drug's continued use despite its cost [3]. That efficacy record is part of why patients often pursue it even when PDE5 inhibitors such as sildenafil or tadalafil are insufficient or contraindicated.

For a 2.5 mcg to 40 mcg dose range of Caverject, the per-injection cost at list price can exceed $25 to $70 per injection depending on the vial configuration purchased. MUSE urethral suppositories (125 mcg to 1 to 000 mcg) carry comparable per-unit costs [4]. Generic injectable alprostadil is now available from several manufacturers, but its cash price in Tennessee pharmacies typically does not fall far below the brand list price without insurance or a discount program.

GoodRx and similar discount platforms can bring the cash price of generic alprostadil injections lower at certain Tennessee pharmacies, sometimes to $350 to $450 per month for select doses, though availability varies by location [5].

Tennessee Medicaid Coverage for Alprostadil

Tennessee Medicaid (TennCare) covers alprostadil only for erectile dysfunction directly associated with type 2 diabetes (T2D). Patients with refractory ED from other causes, such as post-prostatectomy nerve damage or vascular disease without a diabetes diagnosis, are generally not covered under the standard TennCare formulary [6].

TennCare is managed through three managed care organizations: BlueCare Tennessee, UnitedHealthcare Community Plan, and Amerigroup Tennessee. Each MCO applies the same overarching state formulary restriction, but prior authorization criteria and step-therapy requirements can differ at the plan level. Patients should confirm coverage directly with their specific MCO before assuming the T2D exception applies to their situation [7].

The American Urological Association (AUA) 2018 Guideline on Erectile Dysfunction states that intracavernosal alprostadil is a second-line therapy when oral PDE5 inhibitors fail or are contraindicated [8]. TennCare often requires documentation of PDE5 inhibitor failure before approving alprostadil even within the T2D coverage category, meaning a prior authorization denial is common on the first submission without adequate clinical documentation.

For patients who do qualify under the T2D criterion, TennCare preferred drug list (PDL) placement determines copay. Preferred status for a generic alprostadil product would typically mean a $3 to $8 copay per fill under TennCare fee-for-service, though MCO plans may vary [9].

Is Compounded Alprostadil Legal in Tennessee?

Compounded alprostadil is legal in Tennessee when prepared by a state-licensed 503A compounding pharmacy. The short answer is yes, a licensed Tennessee compounding pharmacy can legally prepare alprostadil injections for individual patients under a valid prescription from a licensed prescriber [10].

Section 503A of the Federal Food, Drug, and Cosmetic Act governs traditional pharmacy compounding. Under 503A, a pharmacy may compound a drug product, including alprostadil, based on a valid patient-specific prescription, provided the compounded drug is not essentially a copy of a commercially available product and the pharmacy meets state licensing requirements [11]. Alprostadil occupies a nuanced position here: because the FDA-approved products (Caverject, MUSE) are commercially available, a 503A pharmacy must document a clinical rationale for why the compounded version is medically necessary for the specific patient. Common justifications include a need for a different concentration, a combination formula (such as the trimix combination of alprostadil, phentolamine, and papaverine), or documented patient intolerance to excipients in the commercial product [12].

Trimix, which contains alprostadil alongside phentolamine and papaverine, is one of the most commonly compounded erectile dysfunction injectables and does not have an FDA-approved commercial equivalent, making its 503A status less legally ambiguous than compounded alprostadil alone [13]. Many Tennessee compounding pharmacies are therefore more comfortable dispensing trimix than a straight alprostadil compound.

The Tennessee Board of Pharmacy regulates 503A pharmacies at the state level and requires compliance with USP 797 sterility standards for any sterile injectable preparation [14]. Patients and prescribers should confirm that a chosen compounding pharmacy holds current Tennessee licensure and has passed recent USP 797 inspections before proceeding.

Cost for compounded alprostadil from a Tennessee 503A pharmacy varies widely. Some compounding pharmacy programs, particularly those operating through telehealth platforms, advertise costs that approach zero dollars per month for qualified patients, though this reflects program pricing structures rather than the actual cost of the compound. A more realistic range for a month of compounded injectable alprostadil from a Tennessee 503A pharmacy is $50 to $150, substantially below the $600 brand retail price.

Which Private Insurance Plans Cover Alprostadil in Tennessee?

Private insurance coverage for alprostadil in Tennessee depends heavily on the specific plan, formulary tier, and whether the plan treats ED medications as a covered benefit. Most commercial plans in Tennessee classify ED treatments as lifestyle drugs and exclude them by default [15].

Plans offered through employers self-insured under ERISA are not required to cover ED medications, and many Tennessee employer plans omit alprostadil entirely. However, fully insured plans regulated by the Tennessee Department of Commerce and Insurance must comply with state insurance law, and Tennessee does not currently mandate coverage of ED medications, meaning exclusions are legal.

When alprostadil is covered on a commercial formulary, it typically lands on Tier 3 or Tier 4, producing copays of $60 to $200 per fill depending on the deductible status and plan design. Blue Cross Blue Shield of Tennessee, Cigna, Aetna, and United Healthcare all operate commercial plans in the state; formulary details change annually and must be verified through the plan's 2026 formulary documents before prescribing [16].

The AUA guideline explicitly notes that cost and insurance coverage are significant barriers to second-line ED therapy access in the United States [8]. Tennessee patients who carry commercial insurance and are denied coverage should ask their prescriber to submit a formal medical necessity appeal with documentation of PDE5 inhibitor failure, cardiovascular contraindications, or other clinical factors.

Medicare Part D covers some alprostadil formulations, but the Part D exclusion for drugs used to treat sexual dysfunction (per 42 CFR 423.120) removes most coverage. A narrow exception exists for alprostadil when prescribed for a non-ED indication, but this does not apply to the vast majority of Tennessee patients seeking the drug for erectile dysfunction [17].

Can Tennessee Patients Get Alprostadil Through Telehealth?

Telehealth prescribing of alprostadil is permitted in Tennessee. A licensed Tennessee provider can evaluate a patient via synchronous audio-video telehealth and issue a valid alprostadil prescription without an in-person visit, provided the evaluation meets the standard of care [18].

Tennessee's telehealth parity law (Tenn. Code Ann. § 56-7-1002) requires commercial insurers to reimburse covered telehealth services at the same rate as in-person care, which means that when alprostadil is a covered benefit, a telehealth consultation to obtain it must be reimbursed equivalently to an office visit [19]. This does not override formulary exclusions, but it removes cost barriers to the prescribing visit itself.

Several national telehealth platforms, including those focused on men's health and hormone therapy, operate in Tennessee and can prescribe alprostadil. These platforms often have affiliated 503A compounding pharmacies that ship directly to Tennessee patients. The practical workflow is a video consultation, prescription issued, compounded product shipped, with total time from consult to delivery typically under one week [20].

The prescribing provider must hold an active Tennessee medical license or an appropriate multistate compact license. Nurse practitioners and physician assistants in Tennessee may prescribe alprostadil under a collaborative practice agreement or under their independent prescribing authority, depending on their license type and the specific arrangement [21].

Savings Programs, Discount Cards, and Manufacturer Assistance

Several cost-reduction options exist for Tennessee patients facing the $600 monthly cash price of brand alprostadil.

Pfizer Copay Card. Pfizer offers a savings card for Caverject through its patient assistance infrastructure. Commercially insured patients (not Medicare or Medicaid) may reduce their out-of-pocket cost to as little as $0 per fill for a defined number of fills per year, subject to program terms. The card does not apply to government-funded insurance programs, so TennCare patients cannot use it [22].

GoodRx and NeedyMeds. GoodRx coupons for generic alprostadil injectable at select Tennessee pharmacies may reduce the price to the $350 to $450 range. NeedyMeds lists patient assistance programs for alprostadil from several manufacturers; income qualification is typically required [5].

Pfizer RxPathways. For uninsured or underinsured Tennessee patients below certain income thresholds, Pfizer's RxPathways program may provide Caverject at no cost. Applications require income documentation and a prescriber signature [22].

Compounding Pharmacy Programs. As noted in the compounding section, licensed Tennessee 503A pharmacies and their affiliated telehealth platforms sometimes bundle the cost of the compound into a monthly membership or subscription fee. Comparing the all-in cost of a telehealth membership against the retail price of the brand is worth doing for uninsured patients.

A 2021 analysis in the Journal of Sexual Medicine found that intracavernosal therapy abandonment rates exceed 50% within 12 months, with cost cited as a primary driver of discontinuation [23]. Tennessee patients who start on brand Caverject at $600 per month and find the price unsustainable should speak with their prescriber about switching to compounded trimix or a lower-cost generic rather than stopping therapy entirely.

Dosing, Administration, and What to Expect

Alprostadil for erectile dysfunction is available as an intracavernosal injection (Caverject, Caverject Impulse, and generic equivalents) and as an intraurethral suppository (MUSE). The two forms differ in efficacy, tolerability, and cost structure [1].

Intracavernosal injection doses range from 1.25 mcg to 40 mcg. The FDA-approved starting dose is 1.25 mcg to 2.5 mcg, titrated upward in a clinical setting until an adequate erection is achieved without a duration exceeding one hour [2]. Patients inject into the lateral aspect of the corpus cavernosum using a 27- or 30-gauge needle. The onset of erection is typically 5 to 20 minutes, with duration of 30 to 60 minutes at the therapeutic dose.

MUSE suppositories range from 125 mcg to 1 to 000 mcg and are inserted into the urethra using an applicator. The MUSE Efficacy and Safety Study (N=1,511) reported that 64.9% of patients had at least one successful intercourse attempt during the 3-month treatment period compared with 18.6% for placebo [24]. Efficacy is generally lower than intracavernosal injection, which partially explains why injection remains the preferred second-line route in clinical practice [8].

Priapism, defined as an erection lasting more than four hours, is the most serious adverse effect. Patients must be counseled to go to an emergency department immediately if an erection persists beyond four hours, as ischemic priapism can cause permanent fibrosis [25]. Pain at the injection site occurs in roughly 37% of patients in clinical trials [3].

How Tennessee Prices Compare to Neighboring States

Tennessee's $600 monthly cash price for brand alprostadil is consistent with the national average and does not differ meaningfully from prices in Georgia, Kentucky, North Carolina, or Virginia. Drug pricing for brand alprostadil is set at the manufacturer level and passed through the pharmaceutical supply chain with relatively small regional variation at retail [26].

Compounded alprostadil prices show more geographic variation because 503A compounding pharmacies set their own pricing. Tennessee patients who are willing to use a mail-order compounding pharmacy licensed in another state (and licensed to ship to Tennessee) may find modestly lower prices, but differences are typically under $30 per month and may not justify the logistics of using an out-of-state pharmacy when Tennessee-licensed options exist [27].

The more significant price difference emerges when comparing brand to compound rather than comparing Tennessee to other states. At $50 to $150 per month for a compounded product versus $600 per month for the brand, the within-state difference between prescribing channels is far larger than any between-state retail price gap.